NASDAQ: CRMDCormedix Inc Stock Ownership - Who owns Cormedix?
Insider buying vs selling
Have Cormedix Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Steven W. Lefkowitz | Director | 2025-04-02 | 20,000 | $4.03 | $80.60kBuy |
| Joseph Todisco | Chief Executive Officer | 2025-04-01 | 59,170 | $3.38 | $199.99kBuy |
| Joseph Todisco | Chief Executive Officer | 2025-01-17 | 23,977 | $12.17 | $291.80kSell |
| Elizabeth Hurlburt | EVP | 2025-01-10 | 5,790 | $11.19 | $64.79kSell |
| Joseph Todisco | Chief Executive Officer | 2025-01-10 | 17,829 | $11.19 | $199.51kSell |
| Erin Mistry | EVP Chief Commercial Officer | 2025-01-10 | 5,689 | $11.19 | $63.66kSell |
| Matthew T. David | Chief Financial Officer | 2025-01-10 | 6,515 | $11.19 | $72.90kSell |
| Kaufman Beth Zelnick | Chief Legal Officer | 2025-01-02 | 11,844 | $8.22 | $97.36kSell |
| Elizabeth Hurlburt | EVP | 2025-01-02 | 11,378 | $8.22 | $93.53kSell |
| Erin Mistry | EVP Chief Commercial Officer | 2025-01-02 | 7,830 | $8.22 | $64.36kSell |
CRMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CRMD insiders and whales buy or sell their stock.
CRMD Shareholders
What type of owners hold Cormedix Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 6.97% | 4,725,975 | $59.07M | Institution |
| Vanguard Group Inc | 5.38% | 3,646,551 | $45.58M | Institution |
| Gary A. Gelbfish | 4.04% | 2,739,743 | $34.25M | Insider |
| Elliott Investment Management LP | 3.60% | 2,444,561 | $30.56M | Institution |
| State Street Corp | 2.27% | 1,539,123 | $19.24M | Institution |
| Geode Capital Management LLC | 2.11% | 1,432,919 | $17.91M | Institution |
| Pharmabio Development Inc | 1.15% | 778,563 | $9.73M | Insider |
| Morgan Stanley | 1.04% | 703,740 | $8.80M | Institution |
| Ubs Group Ag | 0.89% | 602,534 | $7.53M | Institution |
| Randy Milby | 0.88% | 599,512 | $7.49M | Insider |
CRMD vs Biotech Stocks
Cormedix Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.